Hiran Orgochem Peer Comparison

BSE: 506170

₹0.48

₹0.02 (4.35%)

As on 30-Mar-2015IST

Market cap

₹5 Cr

Revenue (TTM)

₹0 Cr

P/E Ratio

5.6

P/B Ratio

-0.1

Div. Yield

0 %

Edit

	Hiran Orgochem	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Market cap (₹ Cr)	5	35,717	27,932	26,719	27,040
Revenue (₹ Cr)	--	3,564	9,205	1,936	1,462
Net Profit (₹ Cr)	0.85	414.00	-371.81	288.22	387.35
Net Margin (%)	--	11.23	-3.93	14.79	26.01
RoE (%)	--	8.38	-3.85	29.77	25.18
Price to Earnings	5.56	87.33	--	92.70	70.01
Price-To-Book	-0.14	7.09	3.49	19.90	15.67

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Hiran Orgochem	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Operating Revenue	0.42	4,481.54	--	39.21	111.75
Total Income	1.30	4,548.09	--	39.54	111.77
Total Expenditure	29.00	3,772.14	--	28.05	103.45
EBITDA	-28.58	709.40	--	11.16	8.29
Depreciation	0.05	145.40	--	5.18	0.72
EBIT	-28.63	564.00	--	5.98	7.58
Interest	0.01	55.21	--	2.37	1.59
Other Income	0.88	66.55	--	0.33	0.02
Exceptional Items	--	61.52	--	--	--
Profit before Tax	-27.76	575.34	--	3.94	6.01
Provision for Tax	--	162.65	--	1.27	1.91
Profit after Tax	-27.76	412.69	--	2.67	4.10

Liabilities (₹ Cr)

	Hiran Orgochem	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Shareholder's Funds	-62.36	3,715.35	--	47.49	14.83
Minority Interest	--	143.95	--	--	--
Non-Current Liabilities	0.69	1,872.46	--	11.98	6.27
Current Liabilities	87.17	1,772.97	--	24.42	37.80
Total Liabilities	25.49	7,504.73	--	83.90	59.21

Assets (₹ Cr)

	Hiran Orgochem	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Non-Current Assets	0.20	3,983.17	--	53.02	11.26
Current Assets	25.29	3,521.56	--	30.88	47.65
Total Assets	25.49	7,504.73	--	83.90	59.21
Total Debt*	65.46	2,010.07	--	26.03	22.92
Net Current Assets	-61.87	1,748.59	--	6.46	9.84
Contingent Liabilities	12.27	295.45	--	0.70	--

Cashflow (₹ Cr)

	Hiran Orgochem	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Cash From Operating Activities	-16.08	354.96	--	10.55	-3.88
Cash Flow from Investing Activities	16.13	-206.63	--	-4.09	-4.44
Cash from Financing Activities	0.00	-75.65	--	-10.21	8.61
Net Cash Inflow / Outflow	0.05	72.68	--	0.34	0.29

Ratios

Profitability Ratios

	Hiran Orgochem	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
ROCE (%)	-102.40	11.25	--	9.04	25.03
ROE (%)	0.00	12.49	--	9.82	31.99
ROA (%)	-54.90	5.84	--	3.33	8.42
EBIT Margin (%)	-6,559.89	17.31	--	29.29	7.44
Net Margin (%)	-2,127.23	9.07	--	6.75	3.66
Cash Profit Margin (%)	-5,838.68	12.43	--	19.93	4.31

Growth Ratios

	Hiran Orgochem	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Revenue Growth (%)	-84.04	-7.22	--	-5.70	46.82
EBIT Growth (%)	-401.51	-27.08	--	-2.08	24.42
Net Profit Growth (%)	-284.66	-51.03	--	-40.70	42.98
EPS Growth (%)	-284.66	-42.48	--	-40.70	42.98
Book Value Growth (%)	-80.22	4.11	--	10.33	37.67

Valuation Ratios

	Hiran Orgochem	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Price / Earnings	0.00	46.73	--	0.00	0.00
Price / Book Value	-0.08	6.09	--	0.00	0.00
Dividend Yield (%)	0.00	1.07	--	--	--
EV/EBITDA	-2.53	27.84	--	4.00	2.87
Market Cap (₹ Cr)	4.74	20,529.92	--	0.00	0.00

Solvency Ratios

	Hiran Orgochem	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Debt to Equity	-1.05	0.55	--	0.55	1.55
Short term debt to equity ratio	-1.04	0.09	--	0.27	0.97
Current Ratio	0.29	1.99	--	1.26	1.26
Quick Ratio	0.28	1.41	--	1.22	0.89
Interest Coverage	-5,278.19	11.42	--	2.66	4.78

Operating Efficiency Ratios

	Hiran Orgochem	Wockhardt	Piramal Pharma	Rubicon Research	Acutaas Chemicals
Debtors to sales (%)	86.60	16.54	--	42.87	21.80
Asset Turnover	0.01	0.64	--	0.49	2.30
Receivable days	3,341.48	49.71	--	143.12	61.92
Inventory Days	824.75	81.88	--	10.03	41.26
Payable days	0.00	136.23	--	216.06	94.00
Cash Conversion Cycle	4,166.23	-4.64	--	-62.91	9.17

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.